These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26486853)

  • 1. Annual review of children with neurofibromatosis type 1.
    Dunning-Davies BM; Parker AP
    Arch Dis Child Educ Pract Ed; 2016 Apr; 101(2):102-11. PubMed ID: 26486853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual review of children with tuberous sclerosis.
    Ng KH; Ng SM; Parker A
    Arch Dis Child Educ Pract Ed; 2015 Jun; 100(3):114-21. PubMed ID: 25112285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1: a multidisciplinary approach to care.
    Hirbe AC; Gutmann DH
    Lancet Neurol; 2014 Aug; 13(8):834-43. PubMed ID: 25030515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type I in Norway. A clinical prevalence study based on a small project].
    Bjłrnstad A; Heiberg A
    Tidsskr Nor Laegeforen; 1996 Oct; 116(26):3108-10. PubMed ID: 8999570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 clinical features and management.
    Scalzone M; Coccia P; Ruggiero A; Riccardi R
    Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1.
    Legius E; Descheemaeker MJ; Fryns JP; Van den Berghe H
    Genet Couns; 1994; 5(3):225-41. PubMed ID: 7811422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
    Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
    Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Molecular Diagnosis of Neurofibromatosis Type 1.
    Shofty B; Constantini S; Ben-Shachar S
    Semin Pediatr Neurol; 2015 Dec; 22(4):234-9. PubMed ID: 26706011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
    Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects.
    Hsieh HY; Fung HC; Wang CJ; Chin SC; Wu T
    Seizure; 2011 Oct; 20(8):606-11. PubMed ID: 21621428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of clinical features in neurofibromatosis 1 (NF1).
    Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
    Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.
    Wolkenstein P; Frèche B; Zeller J; Revuz J
    Arch Dermatol; 1996 Nov; 132(11):1333-6. PubMed ID: 8915311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.